Full Validation and Application to Clinical Research of a High-Performance Liquid Chromatography Method for the Assessment of Urinary 3-Indoxyl Sulfate in Pediatric Patients with Hematopoietic Stem Cell Transplant
Open Access
- 19 August 2024
- journal article
- research article
- Published by MDPI AG in Methods and Protocols
- Vol. 7 (4) , 64
Abstract
3-indoxyl sulfate (3-IS) results from a hepatic transformation of indole, a tryptophan degradation product produced by commensal gut bacteria. The metabolite has shown promise as a biomarker of dysbiosis and clinical outcomes following hematopoietic stem cell transplant (HSCT) in adults. Nonetheless, there is a paucity of data regarding microbiome health and outcomes in the pediatric HSCT setting. We developed and thoroughly validated an affordable high-performance liquid chromatography/fluorescence detector (HPLC-FLD) method to quantify 3-IS in urine for use in the pediatric setting. Chromatographic separation was achieved on a C18 column (250 × 4.6 mm × 5 μm) with a mobile phase consisting of pH 4.0 acetic acid-triethylamine buffer and acetonitrile (88:12, v/v), eluted isocratically at 1 mL/min. 3-IS fluorescence detection was set at excitation/emission of 280 and 375, respectively. The method was fully validated according to FDA-specified limits including selectivity, linearity (0.10 to 10.00 mg/L, r2 > 0.997), intra- and inter-day accuracy, and precision. 3-IS stability was confirmed after three freeze–thaw cycles, for short- and medium-term on a benchtop and at 4 °C and for long-term up to 60 days at −20 °C. The validated method was used to quantify 3-IS in urine samples from HSCT pediatric patients.Keywords
Funding Information
- National Agency for the promotion of Research, Technological Development and Innovation under the Programa de Innovacion Federal, contrato PRESTAMO BID (PICTO-UCTH 2021-00004)
This publication has 47 references indexed in Scilit:
- Rapid and sustainable HPLC method for the determination of uremic toxins in human plasma samplesAnalytical and Bioanalytical Chemistry, 2022
- Microbiota Disruption Induced by Early Use of Broad-Spectrum Antibiotics Is an Independent Risk Factor of Outcome after Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2017
- Antibiotic-Induced Depletion of Anti-inflammatory Clostridia Is Associated with the Development of Graft-versus-Host Disease in Pediatric Stem Cell Transplantation PatientsTransplantation and Cellular Therapy, 2017
- Intestinal microbiota-related effects on graft-versus-host diseaseInternational Journal of Hematology, 2015
- Metagenomic Analysis of the Stool Microbiome in Patients Receiving Allogeneic Stem Cell Transplantation: Loss of Diversity Is Associated with Use of Systemic Antibiotics and More Pronounced in Gastrointestinal Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2014
- Quantitative profiling of tryptophan metabolites in serum, urine, and cell culture supernatants by liquid chromatography–tandem mass spectrometryAnalytical and Bioanalytical Chemistry, 2011
- Systematic comparisons of artificial urine formulas for in vitro cellular studyAnalytical Biochemistry, 2010
- Development and validation of a ultra performance LC‐ESI/MS method for analysis of metabolic phenotypes of healthy men in day and night urine samplesJournal of Separation Science, 2008
- Pharmacokinetics and tissue distribution of uraemic indoxyl sulphate in ratsBiopharmaceutics & Drug Disposition, 2003
- Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfateEuropean Journal of Drug Metabolism and Pharmacokinetics, 2002